Meeting
2012 Breast Cancer Symposium
Mutation analysis of PALB2 in high-risk and lower-risk patients negative for BRCA1 and BRCA2 mutations.
Authors
Shelly Cummings
Myriad Genetic Laboratories, Inc.
Shelly Cummings , Jenny Peterson , Elisha Hughes , Rajesh Kaldate , Sonia Chen , Jeffrey Trost , Christopher Arnell , Jennifer Saam , Benjamin Roa , Priscilla Fernandes
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session A
Track
Risk Assessment, Prevention, Detection, and Screening
Sub Track
Genomics
Citation
J Clin Oncol 30, 2012 (suppl 27; abstr 30)
DOI
10.1200/jco.2012.30.27_suppl.30
Abstract #
30
Poster Bd #
C15
Abstract Disclosures
Similar Posters
Poster
2015 Breast Cancer Symposium
Benefits and safety of multigene panel testing in patients at risk for hereditary breast cancer.
First Author: Nimmi S. Kapoor
First Author: Mallika Sachdev Dhawan
First Author: Mallika Sachdev Dhawan
Poster
2016 ASCO Annual Meeting
Incidence of germline mutations in risk genes including BRCA1/2 in consecutive ovarian cancer (OC) patients (AGO TR-1).
First Author: Philipp Harter